Get the Stockscreener App
17.18
1.77%
-0.31
After Hours:
17.17
-0.010
-0.06%
Fulgent Genetics Inc stock is traded at $17.18, with a volume of 441.18K.
It is down -1.77% in the last 24 hours and down -13.58% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$17.49
Open:
$17.34
24h Volume:
441.18K
Relative Volume:
1.50
Market Cap:
$523.02M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-3.135
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
-6.68%
1M Performance:
-13.58%
6M Performance:
+3.25%
1Y Performance:
-28.21%
1-Day Range:
$16.98
$17.52
1-Week Range:
$16.98
$18.60
52-Week Range:
$14.76
$25.11
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
17.18 | 532.46M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Bank of New York Mellon Corp - MarketBeat
Fulgent Genetics Inc. Earnings Report Breakdown: What Investors Should KnowTen-Year Sector Performance and Summary Analysis - Newser
Fulgent Genetics Inc. Forms Bullish Flag — Upside AheadLow Risk Swing Trade Opportunities Identified - metal.it
Why Fulgent Genetics Inc. stock attracts strong analyst attentionSecure Return Focused Investment Plan Released - beatles.ru
Is Fulgent Genetics Inc. a Top Dividend Stock to Watch in 2025Real-Time Trade Insights Spark Market Reactions - metal.it
GSA Capital Partners LLP Has $1.77 Million Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Y Intercept Hong Kong Ltd Invests $1.05 Million in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
When is Fulgent Genetics Inc. stock expected to show significant growthBeginner Investor Tips With Low Risk - jammulinksnews.com
Fulgent Genetics (FLGT) Expected to Announce Earnings on Friday - MarketBeat
How strong is Fulgent Genetics Inc. company’s balance sheetAchieve breakthrough financial results today - jammulinksnews.com
Is Fulgent Genetics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside High Accuracy Trade Setup Identification - metal.it
What institutional investors are buying Fulgent Genetics Inc. stockUnmatched market gains - jammulinksnews.com
What are the latest earnings results for Fulgent Genetics Inc.Capitalize on market trends with confidence - jammulinksnews.com
What is the dividend policy of Fulgent Genetics Inc. stockMaximize returns with expert trading insights - jammulinksnews.com
How many analysts rate Fulgent Genetics Inc. as a “Buy”Get daily updates on the hottest stocks - jammulinksnews.com
What makes Fulgent Genetics Inc. stock price move sharplyPhenomenal trading returns - jammulinksnews.com
What is Fulgent Genetics Inc. company’s growth strategyBuild a diversified portfolio for steady growth - jammulinksnews.com
How does Fulgent Genetics Inc. generate profit in a changing economyMaximize portfolio value with expert tips - jammulinksnews.com
What are Fulgent Genetics Inc. company’s key revenue driversSignificant capital appreciation - jammulinksnews.com
What drives Fulgent Genetics Inc. stock priceFast-track wealth growth - PrintWeekIndia
Is Fulgent Genetics Inc. a good long term investmentDynamic profit expansion - PrintWeekIndia
Will Fulgent Genetics Inc. stock benefit from interest rate changesFree Stock Market Return Analysis - jammulinksnews.com
How Fulgent Genetics Inc. stock reacts to Fed policy changesFree Stock Market Return Analysis - jammulinksnews.com
Fulgent Genetics Inc. Stock Analysis and ForecastOutstanding stock performance - PrintWeekIndia
What analysts say about Fulgent Genetics Inc. stockTriple-digit returns - Autocar Professional
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript - MSN
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):